Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Biosimilar Product'

Biosimilar Product published presentations and documents on DocSlides.

MODULE 8. Follow-on drugs: generic, biosimilar

MODULE 8. Follow-on drugs: generic, biosimilar

  • alida-meadow
  • 0 Slides

& non-biological similar medicinal products ....

U.S. Biosimilars: An Introduction

U.S. Biosimilars: An Introduction

  • calandra-battersby
  • 0 Slides

Disclaimers. :. By 2016, 7 of the top 10 pharmace...

The generic and biosimilar

The generic and biosimilar

  • alida-meadow
  • 0 Slides

perspective. Warwick Smith. Director General BGMA...

Is Australia ready for

Is Australia ready for

  • liane-varnes
  • 12 Slides

biosimilar. . ?. David Lim, Julie Hepworth, Lis...

Acceptable changes in quality attributes of glycosylated bi

Acceptable changes in quality attributes of glycosylated bi

  • debby-jeon
  • 19 Slides

Schiestl M, Stangler T, Torella C, et al. . Nat B...

Biosimilars in RA: A Blessing or a Curse?

Biosimilars in RA: A Blessing or a Curse?

  • conchita-marotz
  • 0 Slides

Introduction/Overview . What Is a Biosimilar?. Di...

Biosimilars in the Real World

Biosimilars in the Real World

  • liane-varnes
  • 0 Slides

Introduction/Overview . PLANETRA Extension Study:...

Understanding Biologics Biologics and Biosimilars

Understanding Biologics Biologics and Biosimilars

  • calandra-battersby
  • 0 Slides

Animation: What Are Biologics?. Production of Bio...

Applying Biosimilars in Hematologic Cancers

Applying Biosimilars in Hematologic Cancers

  • conchita-marotz
  • 0 Slides

This program will include a discussion of off-lab...

United Spinal Association

United Spinal Association

  • alida-meadow
  • 0 Slides

August, 2014. Biologics & Biosimilars: . An O...

Application of Biosimilars in RA IN Clinical Practice:

Application of Biosimilars in RA IN Clinical Practice:

  • conchita-marotz
  • 0 Slides

Key Issues and Challenges.  . Introduction. Diff...

Budget impact and cost-effectiveness of oncology

Budget impact and cost-effectiveness of oncology

  • roxanne
  • 14 Slides

biosimilars. Prof. dr. Steven Simoens. Health econ...

  What is the value of Real-World Evidence for Biosimilars?

  What is the value of Real-World Evidence for Biosimilars?

  • bitsy
  • 82 Slides

Disclaimer. This panel is moderated by Dr. Delphin...

FDA Approves First Biosimilar Sandozs Zarxio By Jennif

FDA Approves First Biosimilar Sandozs Zarxio By Jennif

  • pamella-moone
  • 2 Slides

Dienes Maria E Doukas Christopher J Betti PhD ...

A QUM partnership approach to regulating

A QUM partnership approach to regulating

  • liane-varnes
  • 18 Slides

biosimilars. in Australia. David Lim, Evan Siege...

Biosimilar biological productEvaluation by the FDA

Biosimilar biological productEvaluation by the FDA

  • alida-meadow
  • 100 Slides

oducts used to diagnose, prevent, of diseases and ...

High-resolution SPR surrogate potency assay to facilitate comparability and biosimilar studies

High-resolution SPR surrogate potency assay to facilitate comparability and biosimilar studies

  • test
  • 0 Slides

Veronica Fridh, GE Healthcare, Uppsala, Sweden No...

About OMICS Group OMICS Group International is an amalgamation of 

About OMICS Group OMICS Group International is an amalgamation of 

  • sherrill-nordquist
  • 0 Slides

Open Access publications.  and worldwide interna...

National Pharmacy Practice

National Pharmacy Practice

  • debby-jeon
  • 0 Slides

Gene Dorr . Area Vice President, PBM Consulting. ...

Improving Your Formulary and Denials Management

Improving Your Formulary and Denials Management

  • trinity
  • 35 Slides

Zinkeng Asonganyi, PharmD. Director of Pharmacy Se...

Challenges in Assessing Therapeutic Equivalence of

Challenges in Assessing Therapeutic Equivalence of

  • thomas
  • 27 Slides

Nanosimilars. Beat . Flühmann. Global Lead NBCD ....

Copyright © 2024 DocSlides. All Rights Reserved